Phosphatidylinositol Diacylglycerol-Lyase [lyasa fosfatidylinositoldiacylglycerolu]
- Terms
-
1-fosfatidylinositolfosfodiesterasa
1-fosfatidylinositolfosfodiesteráza
1-fosfatidylinozitolfosfodiesteráza
fosfatidylinositol-diacylglycerol-lyasa
fosfatidylinositol-diacylglycerol-lyáza
fosfatidylinozitol-diacylglycerol-lyáza
-
1-Phosphatidylinositol Phosphodiesterase
Monophosphatidylinositol Phosphodiesterase
A phosphorus-oxygen lyase found primarily in BACTERIA. The enzyme catalyzes the cleavage of a phosphoester linkage in 1-phosphatidyl-1D-myo-inositol to form 1D-myo-inositol 1,2-cyclic phosphate and diacylglycerol. The enzyme was formerly classified as a phosphoric diester hydrolase (EC 3.1.4.10) and is often referred to as a TYPE C PHOSPHOLIPASES. However it is now known that a cyclic phosphate is the final product of this enzyme and that water does not enter into the reaction.
- Annotation
- note X refs: TYPE C PHOSPHOLIPASES is also available
- DUI
- D043265 MeSH Browser
- CUI
- M0077159
- Previous indexing
- Phosphatidylinositols (1977-1982); Phospholipase C (1998-2003); Phosphoric Diester Hydrolases (1976-1997)
- History note
- 2004; use PHOSPHOTIDYLINOSITOL DIACYLGLYCEROL-LYASE (NM) 1980-2003
- Public note
- 2004; 1-PHOSPHATYDYLINOSITOL-GLYCAN-SPECIFIC PHOSPHOLIPASE C (now PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE) was indexed under PHOSPHOLIPASE C 1998-2003; under PHOSPHORIC DIESTER HYDROLASES 1976-1997 & under PHOSPHATIDYLINOSITOLS 1977-1982
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0